News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

LadaTech Announces Illumina, Inc. (ILMN) Found to Infringe Patent



3/1/2012 9:52:47 AM

LARCHMONT, N.Y.--(BUSINESS WIRE)--LadaTech LLC, which is jointly owned by GlaxoSmithKline (GSK) and IP Finance Holdings, announced today that a jury has found that Illumina Inc. (ILMN) has infringed a patent owned by LadaTech covering essential aspects of the Solexa DNA sequencing technology in a major patent infringement lawsuit in Delaware. (LadaTech, LLC v. Illumina, Inc. and Solexa, Inc., in the United States District Court for the District of Delaware (C. A. No. 09-627-SLR))

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES